nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—P2RY12—coronary artery disease	0.27	1	CbGaD
Treprostinil—Nadolol—Penbutolol—coronary artery disease	0.204	1	CrCrCtD
Treprostinil—P2RY12—Ticagrelor—coronary artery disease	0.184	0.526	CbGbCtD
Treprostinil—P2RY12—Clopidogrel—coronary artery disease	0.114	0.325	CbGbCtD
Treprostinil—CYP2C9—Fenofibrate—coronary artery disease	0.00801	0.0229	CbGbCtD
Treprostinil—CYP2C9—Gemfibrozil—coronary artery disease	0.0064	0.0183	CbGbCtD
Treprostinil—CYP2C9—Clopidogrel—coronary artery disease	0.00555	0.0158	CbGbCtD
Treprostinil—PTGIR—pulmonary artery—coronary artery disease	0.00553	0.239	CbGeAlD
Treprostinil—CYP2C9—cardial valve—coronary artery disease	0.00488	0.211	CbGeAlD
Treprostinil—CYP2C9—Pitavastatin—coronary artery disease	0.00485	0.0138	CbGbCtD
Treprostinil—CYP2C9—Valsartan—coronary artery disease	0.00472	0.0135	CbGbCtD
Treprostinil—CYP2C9—Rosuvastatin—coronary artery disease	0.00358	0.0102	CbGbCtD
Treprostinil—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00349	0.00995	CbGbCtD
Treprostinil—CYP2C9—Simvastatin—coronary artery disease	0.00333	0.00949	CbGbCtD
Treprostinil—CYP2C9—Lovastatin—coronary artery disease	0.00325	0.00929	CbGbCtD
Treprostinil—CYP2C9—Pravastatin—coronary artery disease	0.00325	0.00929	CbGbCtD
Treprostinil—P2RY12—artery—coronary artery disease	0.00322	0.139	CbGeAlD
Treprostinil—CYP2C9—Atorvastatin—coronary artery disease	0.00296	0.00846	CbGbCtD
Treprostinil—CYP2C9—Losartan—coronary artery disease	0.00271	0.00774	CbGbCtD
Treprostinil—PTGIR—artery—coronary artery disease	0.00205	0.0886	CbGeAlD
Treprostinil—PTGIR—endothelium—coronary artery disease	0.00173	0.0748	CbGeAlD
Treprostinil—Epoprostenol—P2RY12—coronary artery disease	0.00113	0.668	CrCbGaD
Treprostinil—P2RY12—cardiovascular system—coronary artery disease	0.00112	0.0482	CbGeAlD
Treprostinil—PPARD—heart—coronary artery disease	0.000984	0.0425	CbGeAlD
Treprostinil—P2RY12—blood—coronary artery disease	0.000884	0.0382	CbGeAlD
Treprostinil—PTGIR—heart—coronary artery disease	0.000755	0.0326	CbGeAlD
Treprostinil—PTGIR—cardiovascular system—coronary artery disease	0.000713	0.0308	CbGeAlD
Treprostinil—PTGIR—blood—coronary artery disease	0.000564	0.0243	CbGeAlD
Treprostinil—Nadolol—ADRB1—coronary artery disease	0.000306	0.18	CrCbGaD
Treprostinil—CYP2C9—heart—coronary artery disease	0.00027	0.0117	CbGeAlD
Treprostinil—Nadolol—ADRB2—coronary artery disease	0.000257	0.152	CrCbGaD
Treprostinil—CYP2C9—cardiovascular system—coronary artery disease	0.000255	0.011	CbGeAlD
Treprostinil—CYP2C9—blood—coronary artery disease	0.000201	0.0087	CbGeAlD
Treprostinil—Chest pain—Ramipril—coronary artery disease	4.33e-05	0.000503	CcSEcCtD
Treprostinil—Fatigue—Furosemide—coronary artery disease	4.32e-05	0.000502	CcSEcCtD
Treprostinil—Abdominal pain—Telmisartan—coronary artery disease	4.32e-05	0.000502	CcSEcCtD
Treprostinil—Body temperature increased—Telmisartan—coronary artery disease	4.32e-05	0.000502	CcSEcCtD
Treprostinil—Dyspnoea—Losartan—coronary artery disease	4.31e-05	0.000501	CcSEcCtD
Treprostinil—Anxiety—Ramipril—coronary artery disease	4.31e-05	0.000501	CcSEcCtD
Treprostinil—Vomiting—Lovastatin—coronary artery disease	4.31e-05	0.0005	CcSEcCtD
Treprostinil—Dizziness—Eplerenone—coronary artery disease	4.3e-05	0.000499	CcSEcCtD
Treprostinil—Rash—Clopidogrel—coronary artery disease	4.3e-05	0.000499	CcSEcCtD
Treprostinil—Dermatitis—Clopidogrel—coronary artery disease	4.29e-05	0.000499	CcSEcCtD
Treprostinil—Asthenia—Valsartan—coronary artery disease	4.29e-05	0.000498	CcSEcCtD
Treprostinil—Pain—Furosemide—coronary artery disease	4.29e-05	0.000498	CcSEcCtD
Treprostinil—Ill-defined disorder—Lisinopril—coronary artery disease	4.28e-05	0.000497	CcSEcCtD
Treprostinil—Discomfort—Ramipril—coronary artery disease	4.27e-05	0.000497	CcSEcCtD
Treprostinil—Asthenia—Olmesartan—coronary artery disease	4.27e-05	0.000496	CcSEcCtD
Treprostinil—Headache—Clopidogrel—coronary artery disease	4.27e-05	0.000496	CcSEcCtD
Treprostinil—Rash—Lovastatin—coronary artery disease	4.27e-05	0.000496	CcSEcCtD
Treprostinil—Dermatitis—Lovastatin—coronary artery disease	4.27e-05	0.000495	CcSEcCtD
Treprostinil—Anaemia—Lisinopril—coronary artery disease	4.26e-05	0.000495	CcSEcCtD
Treprostinil—Dyspepsia—Losartan—coronary artery disease	4.26e-05	0.000495	CcSEcCtD
Treprostinil—Feeling abnormal—Perindopril—coronary artery disease	4.25e-05	0.000494	CcSEcCtD
Treprostinil—Headache—Lovastatin—coronary artery disease	4.24e-05	0.000493	CcSEcCtD
Treprostinil—Pruritus—Valsartan—coronary artery disease	4.23e-05	0.000492	CcSEcCtD
Treprostinil—Chest pain—Timolol—coronary artery disease	4.23e-05	0.000491	CcSEcCtD
Treprostinil—Arthralgia—Timolol—coronary artery disease	4.23e-05	0.000491	CcSEcCtD
Treprostinil—Myalgia—Timolol—coronary artery disease	4.23e-05	0.000491	CcSEcCtD
Treprostinil—Vomiting—Ezetimibe—coronary artery disease	4.22e-05	0.00049	CcSEcCtD
Treprostinil—Gastrointestinal pain—Perindopril—coronary artery disease	4.22e-05	0.00049	CcSEcCtD
Treprostinil—Anxiety—Timolol—coronary artery disease	4.22e-05	0.00049	CcSEcCtD
Treprostinil—Angioedema—Lisinopril—coronary artery disease	4.21e-05	0.000489	CcSEcCtD
Treprostinil—Pruritus—Olmesartan—coronary artery disease	4.21e-05	0.000489	CcSEcCtD
Treprostinil—Decreased appetite—Losartan—coronary artery disease	4.21e-05	0.000488	CcSEcCtD
Treprostinil—Abdominal pain—Captopril—coronary artery disease	4.2e-05	0.000488	CcSEcCtD
Treprostinil—Body temperature increased—Captopril—coronary artery disease	4.2e-05	0.000488	CcSEcCtD
Treprostinil—Dizziness—Simvastatin—coronary artery disease	4.19e-05	0.000486	CcSEcCtD
Treprostinil—Rash—Ezetimibe—coronary artery disease	4.19e-05	0.000486	CcSEcCtD
Treprostinil—Dermatitis—Ezetimibe—coronary artery disease	4.18e-05	0.000486	CcSEcCtD
Treprostinil—Discomfort—Timolol—coronary artery disease	4.18e-05	0.000485	CcSEcCtD
Treprostinil—Asthenia—Niacin—coronary artery disease	4.17e-05	0.000485	CcSEcCtD
Treprostinil—Fatigue—Losartan—coronary artery disease	4.17e-05	0.000484	CcSEcCtD
Treprostinil—Headache—Ezetimibe—coronary artery disease	4.16e-05	0.000483	CcSEcCtD
Treprostinil—Malaise—Lisinopril—coronary artery disease	4.16e-05	0.000483	CcSEcCtD
Treprostinil—Oedema—Ramipril—coronary artery disease	4.15e-05	0.000482	CcSEcCtD
Treprostinil—Pain—Losartan—coronary artery disease	4.14e-05	0.00048	CcSEcCtD
Treprostinil—Syncope—Lisinopril—coronary artery disease	4.13e-05	0.00048	CcSEcCtD
Treprostinil—Vomiting—Eplerenone—coronary artery disease	4.13e-05	0.00048	CcSEcCtD
Treprostinil—Feeling abnormal—Furosemide—coronary artery disease	4.13e-05	0.00048	CcSEcCtD
Treprostinil—Nausea—Fenofibrate—coronary artery disease	4.12e-05	0.000478	CcSEcCtD
Treprostinil—Pruritus—Niacin—coronary artery disease	4.11e-05	0.000478	CcSEcCtD
Treprostinil—Asthenia—Pravastatin—coronary artery disease	4.11e-05	0.000477	CcSEcCtD
Treprostinil—Gastrointestinal pain—Furosemide—coronary artery disease	4.1e-05	0.000476	CcSEcCtD
Treprostinil—Rash—Eplerenone—coronary artery disease	4.1e-05	0.000476	CcSEcCtD
Treprostinil—Dermatitis—Eplerenone—coronary artery disease	4.09e-05	0.000476	CcSEcCtD
Treprostinil—Diarrhoea—Valsartan—coronary artery disease	4.09e-05	0.000475	CcSEcCtD
Treprostinil—Shock—Ramipril—coronary artery disease	4.08e-05	0.000474	CcSEcCtD
Treprostinil—Body temperature increased—Perindopril—coronary artery disease	4.08e-05	0.000474	CcSEcCtD
Treprostinil—Abdominal pain—Perindopril—coronary artery disease	4.08e-05	0.000474	CcSEcCtD
Treprostinil—Palpitations—Lisinopril—coronary artery disease	4.07e-05	0.000473	CcSEcCtD
Treprostinil—Diarrhoea—Olmesartan—coronary artery disease	4.07e-05	0.000473	CcSEcCtD
Treprostinil—Headache—Eplerenone—coronary artery disease	4.07e-05	0.000473	CcSEcCtD
Treprostinil—Thrombocytopenia—Ramipril—coronary artery disease	4.06e-05	0.000472	CcSEcCtD
Treprostinil—Oedema—Timolol—coronary artery disease	4.05e-05	0.000471	CcSEcCtD
Treprostinil—Pruritus—Pravastatin—coronary artery disease	4.05e-05	0.000471	CcSEcCtD
Treprostinil—Loss of consciousness—Lisinopril—coronary artery disease	4.05e-05	0.000471	CcSEcCtD
Treprostinil—Nausea—Clopidogrel—coronary artery disease	4.05e-05	0.00047	CcSEcCtD
Treprostinil—Tachycardia—Ramipril—coronary artery disease	4.05e-05	0.00047	CcSEcCtD
Treprostinil—Infection—Timolol—coronary artery disease	4.03e-05	0.000468	CcSEcCtD
Treprostinil—Vomiting—Simvastatin—coronary artery disease	4.03e-05	0.000468	CcSEcCtD
Treprostinil—Cough—Lisinopril—coronary artery disease	4.02e-05	0.000467	CcSEcCtD
Treprostinil—Nausea—Lovastatin—coronary artery disease	4.02e-05	0.000467	CcSEcCtD
Treprostinil—Rash—Simvastatin—coronary artery disease	3.99e-05	0.000464	CcSEcCtD
Treprostinil—Dermatitis—Simvastatin—coronary artery disease	3.99e-05	0.000463	CcSEcCtD
Treprostinil—Asthenia—Trandolapril—coronary artery disease	3.99e-05	0.000463	CcSEcCtD
Treprostinil—Shock—Timolol—coronary artery disease	3.99e-05	0.000463	CcSEcCtD
Treprostinil—Feeling abnormal—Losartan—coronary artery disease	3.99e-05	0.000463	CcSEcCtD
Treprostinil—Diarrhoea—Niacin—coronary artery disease	3.98e-05	0.000462	CcSEcCtD
Treprostinil—Asthenia—Enalapril—coronary artery disease	3.97e-05	0.000462	CcSEcCtD
Treprostinil—Headache—Simvastatin—coronary artery disease	3.97e-05	0.000461	CcSEcCtD
Treprostinil—Body temperature increased—Furosemide—coronary artery disease	3.96e-05	0.00046	CcSEcCtD
Treprostinil—Abdominal pain—Furosemide—coronary artery disease	3.96e-05	0.00046	CcSEcCtD
Treprostinil—Gastrointestinal pain—Losartan—coronary artery disease	3.96e-05	0.000459	CcSEcCtD
Treprostinil—Dizziness—Valsartan—coronary artery disease	3.96e-05	0.000459	CcSEcCtD
Treprostinil—Anorexia—Ramipril—coronary artery disease	3.95e-05	0.000459	CcSEcCtD
Treprostinil—Nausea—Ezetimibe—coronary artery disease	3.94e-05	0.000458	CcSEcCtD
Treprostinil—Dizziness—Olmesartan—coronary artery disease	3.94e-05	0.000457	CcSEcCtD
Treprostinil—Pruritus—Trandolapril—coronary artery disease	3.93e-05	0.000457	CcSEcCtD
Treprostinil—Arthralgia—Lisinopril—coronary artery disease	3.92e-05	0.000456	CcSEcCtD
Treprostinil—Chest pain—Lisinopril—coronary artery disease	3.92e-05	0.000456	CcSEcCtD
Treprostinil—Myalgia—Lisinopril—coronary artery disease	3.92e-05	0.000456	CcSEcCtD
Treprostinil—Asthenia—Telmisartan—coronary artery disease	3.92e-05	0.000455	CcSEcCtD
Treprostinil—Pruritus—Enalapril—coronary artery disease	3.92e-05	0.000455	CcSEcCtD
Treprostinil—Diarrhoea—Pravastatin—coronary artery disease	3.92e-05	0.000455	CcSEcCtD
Treprostinil—Anxiety—Lisinopril—coronary artery disease	3.91e-05	0.000454	CcSEcCtD
Treprostinil—Discomfort—Lisinopril—coronary artery disease	3.88e-05	0.00045	CcSEcCtD
Treprostinil—Hypotension—Ramipril—coronary artery disease	3.88e-05	0.00045	CcSEcCtD
Treprostinil—Anorexia—Timolol—coronary artery disease	3.87e-05	0.000449	CcSEcCtD
Treprostinil—Pruritus—Telmisartan—coronary artery disease	3.86e-05	0.000449	CcSEcCtD
Treprostinil—Nausea—Eplerenone—coronary artery disease	3.86e-05	0.000448	CcSEcCtD
Treprostinil—Dizziness—Niacin—coronary artery disease	3.85e-05	0.000447	CcSEcCtD
Treprostinil—Abdominal pain—Losartan—coronary artery disease	3.82e-05	0.000444	CcSEcCtD
Treprostinil—Body temperature increased—Losartan—coronary artery disease	3.82e-05	0.000444	CcSEcCtD
Treprostinil—Asthenia—Captopril—coronary artery disease	3.81e-05	0.000443	CcSEcCtD
Treprostinil—Diarrhoea—Trandolapril—coronary artery disease	3.8e-05	0.000442	CcSEcCtD
Treprostinil—Vomiting—Valsartan—coronary artery disease	3.8e-05	0.000442	CcSEcCtD
Treprostinil—Diarrhoea—Enalapril—coronary artery disease	3.79e-05	0.00044	CcSEcCtD
Treprostinil—Hypotension—Timolol—coronary artery disease	3.79e-05	0.00044	CcSEcCtD
Treprostinil—Dizziness—Pravastatin—coronary artery disease	3.79e-05	0.00044	CcSEcCtD
Treprostinil—Vomiting—Olmesartan—coronary artery disease	3.78e-05	0.00044	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Ramipril—coronary artery disease	3.78e-05	0.000439	CcSEcCtD
Treprostinil—Rash—Valsartan—coronary artery disease	3.77e-05	0.000438	CcSEcCtD
Treprostinil—Dermatitis—Valsartan—coronary artery disease	3.77e-05	0.000438	CcSEcCtD
Treprostinil—Nausea—Simvastatin—coronary artery disease	3.76e-05	0.000437	CcSEcCtD
Treprostinil—Oedema—Lisinopril—coronary artery disease	3.76e-05	0.000437	CcSEcCtD
Treprostinil—Pruritus—Captopril—coronary artery disease	3.76e-05	0.000437	CcSEcCtD
Treprostinil—Rash—Olmesartan—coronary artery disease	3.75e-05	0.000436	CcSEcCtD
Treprostinil—Insomnia—Ramipril—coronary artery disease	3.75e-05	0.000436	CcSEcCtD
Treprostinil—Dermatitis—Olmesartan—coronary artery disease	3.75e-05	0.000436	CcSEcCtD
Treprostinil—Headache—Valsartan—coronary artery disease	3.75e-05	0.000435	CcSEcCtD
Treprostinil—Diarrhoea—Telmisartan—coronary artery disease	3.74e-05	0.000434	CcSEcCtD
Treprostinil—Infection—Lisinopril—coronary artery disease	3.74e-05	0.000434	CcSEcCtD
Treprostinil—Headache—Olmesartan—coronary artery disease	3.73e-05	0.000433	CcSEcCtD
Treprostinil—Paraesthesia—Ramipril—coronary artery disease	3.72e-05	0.000433	CcSEcCtD
Treprostinil—Shock—Lisinopril—coronary artery disease	3.7e-05	0.00043	CcSEcCtD
Treprostinil—Asthenia—Perindopril—coronary artery disease	3.7e-05	0.00043	CcSEcCtD
Treprostinil—Dyspnoea—Ramipril—coronary artery disease	3.7e-05	0.00043	CcSEcCtD
Treprostinil—Vomiting—Niacin—coronary artery disease	3.7e-05	0.00043	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Timolol—coronary artery disease	3.69e-05	0.000429	CcSEcCtD
Treprostinil—Thrombocytopenia—Lisinopril—coronary artery disease	3.68e-05	0.000428	CcSEcCtD
Treprostinil—Dizziness—Trandolapril—coronary artery disease	3.68e-05	0.000427	CcSEcCtD
Treprostinil—Tachycardia—Lisinopril—coronary artery disease	3.67e-05	0.000426	CcSEcCtD
Treprostinil—Insomnia—Timolol—coronary artery disease	3.67e-05	0.000426	CcSEcCtD
Treprostinil—Rash—Niacin—coronary artery disease	3.67e-05	0.000426	CcSEcCtD
Treprostinil—Dermatitis—Niacin—coronary artery disease	3.66e-05	0.000426	CcSEcCtD
Treprostinil—Dizziness—Enalapril—coronary artery disease	3.66e-05	0.000425	CcSEcCtD
Treprostinil—Dyspepsia—Ramipril—coronary artery disease	3.65e-05	0.000424	CcSEcCtD
Treprostinil—Pruritus—Perindopril—coronary artery disease	3.65e-05	0.000424	CcSEcCtD
Treprostinil—Headache—Niacin—coronary artery disease	3.64e-05	0.000423	CcSEcCtD
Treprostinil—Paraesthesia—Timolol—coronary artery disease	3.64e-05	0.000423	CcSEcCtD
Treprostinil—Vomiting—Pravastatin—coronary artery disease	3.64e-05	0.000423	CcSEcCtD
Treprostinil—Diarrhoea—Captopril—coronary artery disease	3.63e-05	0.000422	CcSEcCtD
Treprostinil—Dyspnoea—Timolol—coronary artery disease	3.62e-05	0.00042	CcSEcCtD
Treprostinil—Dizziness—Telmisartan—coronary artery disease	3.61e-05	0.00042	CcSEcCtD
Treprostinil—Rash—Pravastatin—coronary artery disease	3.61e-05	0.000419	CcSEcCtD
Treprostinil—Dermatitis—Pravastatin—coronary artery disease	3.61e-05	0.000419	CcSEcCtD
Treprostinil—Decreased appetite—Ramipril—coronary artery disease	3.61e-05	0.000419	CcSEcCtD
Treprostinil—Asthenia—Furosemide—coronary artery disease	3.6e-05	0.000418	CcSEcCtD
Treprostinil—Headache—Pravastatin—coronary artery disease	3.59e-05	0.000417	CcSEcCtD
Treprostinil—Anorexia—Lisinopril—coronary artery disease	3.59e-05	0.000417	CcSEcCtD
Treprostinil—Fatigue—Ramipril—coronary artery disease	3.58e-05	0.000415	CcSEcCtD
Treprostinil—Dyspepsia—Timolol—coronary artery disease	3.57e-05	0.000415	CcSEcCtD
Treprostinil—Nausea—Valsartan—coronary artery disease	3.55e-05	0.000413	CcSEcCtD
Treprostinil—Pruritus—Furosemide—coronary artery disease	3.55e-05	0.000412	CcSEcCtD
Treprostinil—Nausea—Olmesartan—coronary artery disease	3.54e-05	0.000411	CcSEcCtD
Treprostinil—Vomiting—Trandolapril—coronary artery disease	3.54e-05	0.000411	CcSEcCtD
Treprostinil—Diarrhoea—Perindopril—coronary artery disease	3.53e-05	0.00041	CcSEcCtD
Treprostinil—Decreased appetite—Timolol—coronary artery disease	3.52e-05	0.000409	CcSEcCtD
Treprostinil—Vomiting—Enalapril—coronary artery disease	3.52e-05	0.000409	CcSEcCtD
Treprostinil—Hypotension—Lisinopril—coronary artery disease	3.52e-05	0.000408	CcSEcCtD
Treprostinil—Dizziness—Captopril—coronary artery disease	3.51e-05	0.000408	CcSEcCtD
Treprostinil—Rash—Trandolapril—coronary artery disease	3.51e-05	0.000407	CcSEcCtD
Treprostinil—Dermatitis—Trandolapril—coronary artery disease	3.5e-05	0.000407	CcSEcCtD
Treprostinil—Fatigue—Timolol—coronary artery disease	3.5e-05	0.000406	CcSEcCtD
Treprostinil—Rash—Enalapril—coronary artery disease	3.49e-05	0.000406	CcSEcCtD
Treprostinil—Dermatitis—Enalapril—coronary artery disease	3.49e-05	0.000405	CcSEcCtD
Treprostinil—Headache—Trandolapril—coronary artery disease	3.48e-05	0.000405	CcSEcCtD
Treprostinil—Vomiting—Telmisartan—coronary artery disease	3.47e-05	0.000403	CcSEcCtD
Treprostinil—Asthenia—Losartan—coronary artery disease	3.47e-05	0.000403	CcSEcCtD
Treprostinil—Headache—Enalapril—coronary artery disease	3.47e-05	0.000403	CcSEcCtD
Treprostinil—Pain—Timolol—coronary artery disease	3.47e-05	0.000403	CcSEcCtD
Treprostinil—Nausea—Niacin—coronary artery disease	3.45e-05	0.000401	CcSEcCtD
Treprostinil—Rash—Telmisartan—coronary artery disease	3.44e-05	0.0004	CcSEcCtD
Treprostinil—Dermatitis—Telmisartan—coronary artery disease	3.44e-05	0.0004	CcSEcCtD
Treprostinil—Diarrhoea—Furosemide—coronary artery disease	3.43e-05	0.000398	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Lisinopril—coronary artery disease	3.43e-05	0.000398	CcSEcCtD
Treprostinil—Pruritus—Losartan—coronary artery disease	3.42e-05	0.000398	CcSEcCtD
Treprostinil—Headache—Telmisartan—coronary artery disease	3.42e-05	0.000397	CcSEcCtD
Treprostinil—Feeling abnormal—Ramipril—coronary artery disease	3.42e-05	0.000397	CcSEcCtD
Treprostinil—Dizziness—Perindopril—coronary artery disease	3.41e-05	0.000396	CcSEcCtD
Treprostinil—Insomnia—Lisinopril—coronary artery disease	3.4e-05	0.000395	CcSEcCtD
Treprostinil—Nausea—Pravastatin—coronary artery disease	3.4e-05	0.000395	CcSEcCtD
Treprostinil—Gastrointestinal pain—Ramipril—coronary artery disease	3.39e-05	0.000394	CcSEcCtD
Treprostinil—Paraesthesia—Lisinopril—coronary artery disease	3.38e-05	0.000392	CcSEcCtD
Treprostinil—Vomiting—Captopril—coronary artery disease	3.38e-05	0.000392	CcSEcCtD
Treprostinil—Dyspnoea—Lisinopril—coronary artery disease	3.35e-05	0.00039	CcSEcCtD
Treprostinil—Rash—Captopril—coronary artery disease	3.35e-05	0.000389	CcSEcCtD
Treprostinil—Dermatitis—Captopril—coronary artery disease	3.35e-05	0.000389	CcSEcCtD
Treprostinil—Feeling abnormal—Timolol—coronary artery disease	3.34e-05	0.000388	CcSEcCtD
Treprostinil—Headache—Captopril—coronary artery disease	3.33e-05	0.000387	CcSEcCtD
Treprostinil—Gastrointestinal pain—Timolol—coronary artery disease	3.32e-05	0.000385	CcSEcCtD
Treprostinil—Dizziness—Furosemide—coronary artery disease	3.32e-05	0.000385	CcSEcCtD
Treprostinil—Dyspepsia—Lisinopril—coronary artery disease	3.31e-05	0.000385	CcSEcCtD
Treprostinil—Diarrhoea—Losartan—coronary artery disease	3.31e-05	0.000384	CcSEcCtD
Treprostinil—Nausea—Trandolapril—coronary artery disease	3.3e-05	0.000384	CcSEcCtD
Treprostinil—Nausea—Enalapril—coronary artery disease	3.29e-05	0.000382	CcSEcCtD
Treprostinil—Vomiting—Perindopril—coronary artery disease	3.28e-05	0.000381	CcSEcCtD
Treprostinil—Abdominal pain—Ramipril—coronary artery disease	3.28e-05	0.000381	CcSEcCtD
Treprostinil—Body temperature increased—Ramipril—coronary artery disease	3.28e-05	0.000381	CcSEcCtD
Treprostinil—Decreased appetite—Lisinopril—coronary artery disease	3.27e-05	0.00038	CcSEcCtD
Treprostinil—Rash—Perindopril—coronary artery disease	3.25e-05	0.000378	CcSEcCtD
Treprostinil—Dermatitis—Perindopril—coronary artery disease	3.25e-05	0.000377	CcSEcCtD
Treprostinil—Nausea—Telmisartan—coronary artery disease	3.24e-05	0.000377	CcSEcCtD
Treprostinil—Fatigue—Lisinopril—coronary artery disease	3.24e-05	0.000377	CcSEcCtD
Treprostinil—Headache—Perindopril—coronary artery disease	3.23e-05	0.000375	CcSEcCtD
Treprostinil—Pain—Lisinopril—coronary artery disease	3.22e-05	0.000374	CcSEcCtD
Treprostinil—Abdominal pain—Timolol—coronary artery disease	3.21e-05	0.000372	CcSEcCtD
Treprostinil—Body temperature increased—Timolol—coronary artery disease	3.21e-05	0.000372	CcSEcCtD
Treprostinil—Dizziness—Losartan—coronary artery disease	3.2e-05	0.000372	CcSEcCtD
Treprostinil—Vomiting—Furosemide—coronary artery disease	3.19e-05	0.00037	CcSEcCtD
Treprostinil—Rash—Furosemide—coronary artery disease	3.16e-05	0.000367	CcSEcCtD
Treprostinil—Dermatitis—Furosemide—coronary artery disease	3.16e-05	0.000367	CcSEcCtD
Treprostinil—Nausea—Captopril—coronary artery disease	3.16e-05	0.000366	CcSEcCtD
Treprostinil—Headache—Furosemide—coronary artery disease	3.14e-05	0.000365	CcSEcCtD
Treprostinil—Feeling abnormal—Lisinopril—coronary artery disease	3.1e-05	0.00036	CcSEcCtD
Treprostinil—Gastrointestinal pain—Lisinopril—coronary artery disease	3.08e-05	0.000357	CcSEcCtD
Treprostinil—Vomiting—Losartan—coronary artery disease	3.08e-05	0.000357	CcSEcCtD
Treprostinil—Nausea—Perindopril—coronary artery disease	3.06e-05	0.000356	CcSEcCtD
Treprostinil—Rash—Losartan—coronary artery disease	3.05e-05	0.000354	CcSEcCtD
Treprostinil—Dermatitis—Losartan—coronary artery disease	3.05e-05	0.000354	CcSEcCtD
Treprostinil—Headache—Losartan—coronary artery disease	3.03e-05	0.000352	CcSEcCtD
Treprostinil—Nausea—Furosemide—coronary artery disease	2.98e-05	0.000346	CcSEcCtD
Treprostinil—Asthenia—Ramipril—coronary artery disease	2.98e-05	0.000346	CcSEcCtD
Treprostinil—Abdominal pain—Lisinopril—coronary artery disease	2.97e-05	0.000345	CcSEcCtD
Treprostinil—Body temperature increased—Lisinopril—coronary artery disease	2.97e-05	0.000345	CcSEcCtD
Treprostinil—Pruritus—Ramipril—coronary artery disease	2.93e-05	0.000341	CcSEcCtD
Treprostinil—Asthenia—Timolol—coronary artery disease	2.91e-05	0.000338	CcSEcCtD
Treprostinil—Nausea—Losartan—coronary artery disease	2.87e-05	0.000334	CcSEcCtD
Treprostinil—Pruritus—Timolol—coronary artery disease	2.87e-05	0.000333	CcSEcCtD
Treprostinil—Diarrhoea—Ramipril—coronary artery disease	2.84e-05	0.00033	CcSEcCtD
Treprostinil—Diarrhoea—Timolol—coronary artery disease	2.77e-05	0.000322	CcSEcCtD
Treprostinil—Dizziness—Ramipril—coronary artery disease	2.74e-05	0.000319	CcSEcCtD
Treprostinil—Asthenia—Lisinopril—coronary artery disease	2.7e-05	0.000313	CcSEcCtD
Treprostinil—Dizziness—Timolol—coronary artery disease	2.68e-05	0.000311	CcSEcCtD
Treprostinil—Pruritus—Lisinopril—coronary artery disease	2.66e-05	0.000309	CcSEcCtD
Treprostinil—Vomiting—Ramipril—coronary artery disease	2.64e-05	0.000306	CcSEcCtD
Treprostinil—Rash—Ramipril—coronary artery disease	2.62e-05	0.000304	CcSEcCtD
Treprostinil—Dermatitis—Ramipril—coronary artery disease	2.61e-05	0.000303	CcSEcCtD
Treprostinil—Headache—Ramipril—coronary artery disease	2.6e-05	0.000302	CcSEcCtD
Treprostinil—Vomiting—Timolol—coronary artery disease	2.58e-05	0.000299	CcSEcCtD
Treprostinil—Diarrhoea—Lisinopril—coronary artery disease	2.57e-05	0.000299	CcSEcCtD
Treprostinil—Rash—Timolol—coronary artery disease	2.56e-05	0.000297	CcSEcCtD
Treprostinil—Dermatitis—Timolol—coronary artery disease	2.55e-05	0.000297	CcSEcCtD
Treprostinil—Headache—Timolol—coronary artery disease	2.54e-05	0.000295	CcSEcCtD
Treprostinil—Dizziness—Lisinopril—coronary artery disease	2.49e-05	0.000289	CcSEcCtD
Treprostinil—Nausea—Ramipril—coronary artery disease	2.46e-05	0.000286	CcSEcCtD
Treprostinil—Nausea—Timolol—coronary artery disease	2.41e-05	0.00028	CcSEcCtD
Treprostinil—Vomiting—Lisinopril—coronary artery disease	2.39e-05	0.000278	CcSEcCtD
Treprostinil—Rash—Lisinopril—coronary artery disease	2.37e-05	0.000276	CcSEcCtD
Treprostinil—Dermatitis—Lisinopril—coronary artery disease	2.37e-05	0.000275	CcSEcCtD
Treprostinil—Headache—Lisinopril—coronary artery disease	2.36e-05	0.000274	CcSEcCtD
Treprostinil—Nausea—Lisinopril—coronary artery disease	2.23e-05	0.00026	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—SOCS3—coronary artery disease	6.33e-06	9.89e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EDN1—coronary artery disease	6.32e-06	9.87e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PDK4—coronary artery disease	6.3e-06	9.83e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SULT4A1—coronary artery disease	6.3e-06	9.83e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PYGM—coronary artery disease	6.3e-06	9.83e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALDH6A1—coronary artery disease	6.3e-06	9.83e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CKMT2—coronary artery disease	6.3e-06	9.83e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—POMC—coronary artery disease	6.28e-06	9.8e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCL5—coronary artery disease	6.27e-06	9.79e-05	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—SERPINE1—coronary artery disease	6.27e-06	9.79e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TGFBR2—coronary artery disease	6.26e-06	9.77e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KITLG—coronary artery disease	6.26e-06	9.77e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—APOE—coronary artery disease	6.21e-06	9.7e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CSF2—coronary artery disease	6.18e-06	9.65e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FGF1—coronary artery disease	6.18e-06	9.65e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—APOA1—coronary artery disease	6.14e-06	9.59e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—LPL—coronary artery disease	6.13e-06	9.58e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—STAT5A—coronary artery disease	6.12e-06	9.55e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MMP3—coronary artery disease	6.12e-06	9.55e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RPS6KB1—coronary artery disease	6.08e-06	9.49e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MEF2C—coronary artery disease	6.08e-06	9.49e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ITGB3—coronary artery disease	5.92e-06	9.25e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APOB—coronary artery disease	5.91e-06	9.23e-05	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—PIK3CA—coronary artery disease	5.88e-06	9.19e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	5.88e-06	9.18e-05	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CXCL8—coronary artery disease	5.86e-06	9.15e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—JAK2—coronary artery disease	5.83e-06	9.11e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EDN1—coronary artery disease	5.82e-06	9.08e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CXCL8—coronary artery disease	5.78e-06	9.03e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCL5—coronary artery disease	5.77e-06	9.01e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PPP2CA—coronary artery disease	5.76e-06	8.99e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CSF2—coronary artery disease	5.69e-06	8.88e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FGF1—coronary artery disease	5.69e-06	8.88e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PRKCD—coronary artery disease	5.65e-06	8.82e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—LPL—coronary artery disease	5.65e-06	8.81e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PFKM—coronary artery disease	5.61e-06	8.76e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GK—coronary artery disease	5.61e-06	8.76e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GYG1—coronary artery disease	5.61e-06	8.76e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LDHA—coronary artery disease	5.61e-06	8.76e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HMGCS2—coronary artery disease	5.61e-06	8.76e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GATM—coronary artery disease	5.61e-06	8.76e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RPS6KB1—coronary artery disease	5.6e-06	8.73e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MEF2C—coronary artery disease	5.6e-06	8.73e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HTR2A—coronary artery disease	5.53e-06	8.63e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—C3—coronary artery disease	5.52e-06	8.62e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—coronary artery disease	5.48e-06	8.56e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—coronary artery disease	5.48e-06	8.56e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—coronary artery disease	5.48e-06	8.56e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ITGB3—coronary artery disease	5.45e-06	8.51e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—coronary artery disease	5.45e-06	8.51e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—coronary artery disease	5.42e-06	8.46e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PPARG—coronary artery disease	5.41e-06	8.45e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GCH1—coronary artery disease	5.35e-06	8.36e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AK1—coronary artery disease	5.35e-06	8.36e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—POMC—coronary artery disease	5.34e-06	8.33e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CXCL8—coronary artery disease	5.32e-06	8.31e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PPP2CA—coronary artery disease	5.3e-06	8.27e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CETP—coronary artery disease	5.29e-06	8.26e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HIF1A—coronary artery disease	5.27e-06	8.22e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AGT—coronary artery disease	5.25e-06	8.19e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—coronary artery disease	5.23e-06	8.17e-05	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—AKT1—coronary artery disease	5.22e-06	8.15e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PRKCD—coronary artery disease	5.2e-06	8.12e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—LEP—coronary artery disease	5.14e-06	8.03e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APOE—coronary artery disease	5.14e-06	8.03e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPAT—coronary artery disease	5.13e-06	8.01e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—MDH2—coronary artery disease	5.13e-06	8.01e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—UGCG—coronary artery disease	5.13e-06	8.01e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PLCD1—coronary artery disease	5.13e-06	8.01e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HTR2A—coronary artery disease	5.09e-06	7.95e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—C3—coronary artery disease	5.08e-06	7.94e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APOA1—coronary artery disease	5.08e-06	7.94e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KDR—coronary artery disease	5.04e-06	7.86e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAPK14—coronary artery disease	5e-06	7.81e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PGM1—coronary artery disease	4.94e-06	7.71e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ESR1—coronary artery disease	4.91e-06	7.66e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ALB—coronary artery disease	4.87e-06	7.6e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—F2—coronary artery disease	4.85e-06	7.57e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FN1—coronary artery disease	4.85e-06	7.57e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HIF1A—coronary artery disease	4.85e-06	7.57e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6ST—coronary artery disease	4.83e-06	7.54e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AGT—coronary artery disease	4.83e-06	7.54e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	4.83e-06	7.54e-05	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—AKT1—coronary artery disease	4.81e-06	7.5e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NFKBIA—coronary artery disease	4.79e-06	7.48e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	4.79e-06	7.47e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PYGB—coronary artery disease	4.77e-06	7.45e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CKB—coronary artery disease	4.77e-06	7.45e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—LEP—coronary artery disease	4.73e-06	7.39e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APOE—coronary artery disease	4.73e-06	7.39e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APOA1—coronary artery disease	4.68e-06	7.3e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—NOS3—coronary artery disease	4.66e-06	7.27e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KIT—coronary artery disease	4.64e-06	7.24e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KDR—coronary artery disease	4.64e-06	7.24e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAPK14—coronary artery disease	4.61e-06	7.19e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ESR1—coronary artery disease	4.52e-06	7.05e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—COX5B—coronary artery disease	4.49e-06	7e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PLIN1—coronary artery disease	4.49e-06	7e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PFKFB3—coronary artery disease	4.49e-06	7e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—DLAT—coronary artery disease	4.49e-06	7e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTM2—coronary artery disease	4.49e-06	7e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—F2—coronary artery disease	4.46e-06	6.97e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FN1—coronary artery disease	4.46e-06	6.97e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GSK3B—coronary artery disease	4.45e-06	6.95e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6ST—coronary artery disease	4.44e-06	6.94e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—POMC—coronary artery disease	4.42e-06	6.9e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CREB1—coronary artery disease	4.42e-06	6.9e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NFKBIA—coronary artery disease	4.41e-06	6.88e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCL2—coronary artery disease	4.32e-06	6.75e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6R—coronary artery disease	4.31e-06	6.73e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KIT—coronary artery disease	4.27e-06	6.67e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	4.27e-06	6.66e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PTGS2—coronary artery disease	4.26e-06	6.65e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SULT1E1—coronary artery disease	4.25e-06	6.64e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IGF1—coronary artery disease	4.25e-06	6.63e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—MAPK1—coronary artery disease	4.23e-06	6.6e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	4.13e-06	6.45e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GSK3B—coronary artery disease	4.1e-06	6.4e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—POMC—coronary artery disease	4.07e-06	6.35e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CREB1—coronary artery disease	4.07e-06	6.35e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HK2—coronary artery disease	4.06e-06	6.33e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AKR1B1—coronary artery disease	4.06e-06	6.33e-05	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PIK3CA—coronary artery disease	4.04e-06	6.31e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SERPINE1—coronary artery disease	4.04e-06	6.3e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCL2—coronary artery disease	3.98e-06	6.21e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6R—coronary artery disease	3.97e-06	6.19e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IGF1—coronary artery disease	3.91e-06	6.1e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FGF2—coronary artery disease	3.91e-06	6.1e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—MAPK1—coronary artery disease	3.89e-06	6.08e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC27A1—coronary artery disease	3.89e-06	6.07e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NOS3—coronary artery disease	3.85e-06	6.01e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LCAT—coronary artery disease	3.81e-06	5.95e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CPT1B—coronary artery disease	3.81e-06	5.95e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOA4—coronary artery disease	3.74e-06	5.84e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—JAK2—coronary artery disease	3.74e-06	5.84e-05	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CA—coronary artery disease	3.72e-06	5.81e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SERPINE1—coronary artery disease	3.71e-06	5.8e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	3.68e-06	5.74e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CA—coronary artery disease	3.67e-06	5.73e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PDHA1—coronary artery disease	3.62e-06	5.64e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GCLM—coronary artery disease	3.62e-06	5.64e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FGF2—coronary artery disease	3.59e-06	5.61e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NOS3—coronary artery disease	3.55e-06	5.53e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	3.51e-06	5.47e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP11B2—coronary artery disease	3.5e-06	5.47e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—TXNRD1—coronary artery disease	3.5e-06	5.47e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC22A3—coronary artery disease	3.45e-06	5.39e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—JAK2—coronary artery disease	3.45e-06	5.38e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CXCL8—coronary artery disease	3.42e-06	5.33e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ARNTL—coronary artery disease	3.4e-06	5.31e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HADH—coronary artery disease	3.4e-06	5.31e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CA—coronary artery disease	3.38e-06	5.27e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	3.35e-06	5.22e-05	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—AKT1—coronary artery disease	3.3e-06	5.15e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CASP3—coronary artery disease	3.27e-06	5.11e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	3.27e-06	5.1e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6—coronary artery disease	3.25e-06	5.07e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOA2—coronary artery disease	3.22e-06	5.03e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GPX2—coronary artery disease	3.22e-06	5.03e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PLA2G2A—coronary artery disease	3.22e-06	5.03e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GPX4—coronary artery disease	3.18e-06	4.97e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SULT1A1—coronary artery disease	3.18e-06	4.97e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HK1—coronary artery disease	3.18e-06	4.97e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ABCG5—coronary artery disease	3.18e-06	4.97e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCND1—coronary artery disease	3.18e-06	4.97e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	3.18e-06	4.96e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HADHA—coronary artery disease	3.15e-06	4.91e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CXCL8—coronary artery disease	3.14e-06	4.91e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTA1—coronary artery disease	3.11e-06	4.85e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MMP9—coronary artery disease	3.09e-06	4.82e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LPA—coronary artery disease	3.07e-06	4.8e-05	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—AKT1—coronary artery disease	3.04e-06	4.74e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CASP3—coronary artery disease	3.01e-06	4.7e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—AKT1—coronary artery disease	3e-06	4.68e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6—coronary artery disease	2.99e-06	4.67e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PLCB3—coronary artery disease	2.98e-06	4.65e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOA5—coronary artery disease	2.95e-06	4.6e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCND1—coronary artery disease	2.93e-06	4.57e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—P4HB—coronary artery disease	2.89e-06	4.51e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	2.86e-06	4.47e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MMP9—coronary artery disease	2.84e-06	4.44e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PLA2G1B—coronary artery disease	2.84e-06	4.43e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	2.81e-06	4.38e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—VEGFA—coronary artery disease	2.78e-06	4.33e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	2.77e-06	4.33e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—AKT1—coronary artery disease	2.76e-06	4.31e-05	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—AKT1—coronary artery disease	2.75e-06	4.3e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—VCAN—coronary artery disease	2.67e-06	4.18e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALDOA—coronary artery disease	2.65e-06	4.14e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CA—coronary artery disease	2.62e-06	4.09e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—DCN—coronary artery disease	2.58e-06	4.02e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—VEGFA—coronary artery disease	2.55e-06	3.99e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TGFB1—coronary artery disease	2.55e-06	3.98e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALDH2—coronary artery disease	2.51e-06	3.91e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAPK1—coronary artery disease	2.5e-06	3.9e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	2.44e-06	3.81e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HBA1—coronary artery disease	2.44e-06	3.81e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LIPC—coronary artery disease	2.44e-06	3.81e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	2.44e-06	3.81e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP2C19—coronary artery disease	2.44e-06	3.81e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOC3—coronary artery disease	2.43e-06	3.79e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LDLR—coronary artery disease	2.41e-06	3.77e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	2.41e-06	3.76e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC9A1—coronary artery disease	2.38e-06	3.72e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTT1—coronary artery disease	2.38e-06	3.72e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GCLC—coronary artery disease	2.36e-06	3.68e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CETP—coronary artery disease	2.36e-06	3.68e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TGFB1—coronary artery disease	2.34e-06	3.66e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SDC1—coronary artery disease	2.33e-06	3.64e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAPK1—coronary artery disease	2.3e-06	3.59e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PSMA6—coronary artery disease	2.2e-06	3.44e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PSMB5—coronary artery disease	2.2e-06	3.44e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	2.2e-06	3.43e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CA—coronary artery disease	2.17e-06	3.38e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CTGF—coronary artery disease	2.15e-06	3.36e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—AKT1—coronary artery disease	2.14e-06	3.34e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HMGCR—coronary artery disease	2.13e-06	3.33e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GOT2—coronary artery disease	2.13e-06	3.33e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CA—coronary artery disease	2e-06	3.11e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PLCB1—coronary artery disease	1.96e-06	3.06e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.92e-06	3e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6—coronary artery disease	1.92e-06	3e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ABCA1—coronary artery disease	1.9e-06	2.97e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GOT1—coronary artery disease	1.84e-06	2.87e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GGT1—coronary artery disease	1.84e-06	2.87e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AKT1—coronary artery disease	1.77e-06	2.76e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6—coronary artery disease	1.77e-06	2.76e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTP1—coronary artery disease	1.65e-06	2.58e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	1.64e-06	2.56e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HMOX1—coronary artery disease	1.63e-06	2.54e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AKT1—coronary artery disease	1.63e-06	2.54e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CAT—coronary artery disease	1.61e-06	2.51e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOB—coronary artery disease	1.56e-06	2.44e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTM1—coronary artery disease	1.52e-06	2.37e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LPL—coronary artery disease	1.49e-06	2.33e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GPX1—coronary artery disease	1.45e-06	2.27e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CD36—coronary artery disease	1.42e-06	2.21e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPP2CA—coronary artery disease	1.4e-06	2.18e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—MTHFR—coronary artery disease	1.34e-06	2.1e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AGT—coronary artery disease	1.28e-06	1.99e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOE—coronary artery disease	1.25e-06	1.95e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOA1—coronary artery disease	1.24e-06	1.93e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.18e-06	1.85e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPARG—coronary artery disease	1.09e-06	1.7e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—POMC—coronary artery disease	1.07e-06	1.68e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALB—coronary artery disease	9.79e-07	1.53e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NOS3—coronary artery disease	9.36e-07	1.46e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTGS2—coronary artery disease	8.56e-07	1.34e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CA—coronary artery disease	5.27e-07	8.22e-06	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AKT1—coronary artery disease	4.3e-07	6.72e-06	CbGpPWpGaD
